These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3955545

  • 21. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB.
    Cancer; 1996 Sep 01; 78(5):998-1003. PubMed ID: 8780537
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P.
    Semin Oncol; 1994 Jun 01; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [Abstract] [Full Text] [Related]

  • 24. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A, Ichiyama S, Shimokata K, Nagura E, Saito H, Saka H, Nomura F, Sakai S, Saito H.
    Nagoya J Med Sci; 1993 Mar 01; 55(1-4):41-6. PubMed ID: 8247105
    [Abstract] [Full Text] [Related]

  • 25. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 26. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R.
    Cancer; 2003 May 15; 97(10):2498-503. PubMed ID: 12733149
    [Abstract] [Full Text] [Related]

  • 27. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
    Yamazaki S, Sekine I, Matsuno Y, Takei H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Asamura H, Tsuchiya R, Saijo N.
    Lung Cancer; 2005 Aug 15; 49(2):217-23. PubMed ID: 16022916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T, Fukuoka M, Negoro S, Sugiura T, Kawahara M, Kudoh S, Araki J, Nakagawa K, Yokozaki M, Yamakido M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1091-6. PubMed ID: 10945001
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P, Manke HG.
    Strahlentherapie; 1985 Mar 15; 161(3):131-3. PubMed ID: 2983459
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
    Sculier JP, Klastersky J, Dumont JP, Vandermoten G, Rocmans P, Libert P, Ravez P, Becquart D, Mommen P, Dalesio O.
    Cancer Treat Rep; 1986 Jun 15; 70(6):773-5. PubMed ID: 3731139
    [Abstract] [Full Text] [Related]

  • 35. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Ardizzoni A, Fusco V, Gulisano M, Pronzato P, Baracco F, Capaccio A, Pastorino G, Nosenzo M, Felletti R, Fabiano F.
    Cancer Treat Rep; 1987 Dec 15; 71(12):1311-2. PubMed ID: 2825994
    [No Abstract] [Full Text] [Related]

  • 36. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
    Dinwoodie WR, Bartolucci AA, Lyman GH, Velez-Garcia E, Martelo OJ, Sarma PR.
    Cancer Treat Rep; 1986 Feb 15; 70(2):267-70. PubMed ID: 2418969
    [Abstract] [Full Text] [Related]

  • 37. Vinblastine plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule.
    Huberman M, Lokich J, Greene R, Paul S, Phillips D, Sonneborn H, Zipoli T.
    Cancer Treat Rep; 1986 Feb 15; 70(2):287-9. PubMed ID: 3004727
    [Abstract] [Full Text] [Related]

  • 38. cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
    Krauss S, Tornyos K, DeSimone P, Lowenbraun S, McKeown J, Solomon A, Sonoda T.
    Cancer Treat Rep; 1979 Mar 15; 63(3):391-3. PubMed ID: 106964
    [Abstract] [Full Text] [Related]

  • 39. [A complete response in squamous cell carcinoma of the lung to combination chemotherapy by cisplatin and vindesine].
    Atsumi M, Fuse Y, Taniwaki M, Takino T, Kataoka K, Takeda S, Tsuji T.
    Gan No Rinsho; 1987 Dec 15; 33(15):1911-4. PubMed ID: 3430743
    [Abstract] [Full Text] [Related]

  • 40. [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
    Fujii M, Kiura K, Okabe K, Toki H.
    Gan To Kagaku Ryoho; 1987 Jan 15; 14(1):105-8. PubMed ID: 3099647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.